Literature DB >> 33577625

PET/MRI for Primary Breast Cancer: A Match Made Better by PET Quantification?

David A Mankoff1, Suleman Surti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33577625      PMCID： PMC7850234          DOI： 10.1148/rycan.2021200150

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN： 2638-616X


× No keyword cloud information.
  10 in total

1.  SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.

Authors:  Sylvain Beaulieu; Paul Kinahan; Jeffrey Tseng; Lisa K Dunnwald; Erin K Schubert; Pam Pham; Barbara Lewellen; David A Mankoff
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

2.  Principles of PET/MR Imaging.

Authors:  Jonathan A Disselhorst; Ilja Bezrukov; Armin Kolb; Christoph Parl; Bernd J Pichler
Journal:  J Nucl Med       Date:  2014-05-12       Impact factor: 10.057

3.  Measuring Glucose Uptake in Primary Invasive Breast Cancer Using Simultaneous Time-of-Flight Breast PET/MRI: A Method Comparison Study with Prone PET/CT.

Authors:  Amy M Fowler; Manoj Kumar; Leah Henze Bancroft; Kelley Salem; Jacob M Johnson; Jillian Karow; Scott B Perlman; Tyler J Bradshaw; Samuel A Hurley; Alan B McMillan; Roberta M Strigel
Journal:  Radiol Imaging Cancer       Date:  2021-01-15

4.  Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.

Authors:  Nola M Hylton; Constantine A Gatsonis; Mark A Rosen; Constance D Lehman; David C Newitt; Savannah C Partridge; Wanda K Bernreuter; Etta D Pisano; Elizabeth A Morris; Paul T Weatherall; Sandra M Polin; Gillian M Newstead; Helga S Marques; Laura J Esserman; Mitchell D Schnall
Journal:  Radiology       Date:  2015-12-01       Impact factor: 11.105

5.  Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.

Authors:  Reinhard Bos; Jacobus J M van Der Hoeven; Elsken van Der Wall; Petra van Der Groep; Paul J van Diest; Emile F I Comans; Urvi Joshi; Gregg L Semenza; Otto S Hoekstra; Adriaan A Lammertsma; Carla F M Molthoff
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

Review 6.  Update on time-of-flight PET imaging.

Authors:  Suleman Surti
Journal:  J Nucl Med       Date:  2014-12-18       Impact factor: 10.057

Review 7.  Imaging Neoadjuvant Therapy Response in Breast Cancer.

Authors:  Amy M Fowler; David A Mankoff; Bonnie N Joe
Journal:  Radiology       Date:  2017-11       Impact factor: 11.105

8.  Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy.

Authors:  Xiaoming Chen; Mark O Moore; Constance D Lehman; David A Mankoff; Thomas J Lawton; Sue Peacock; Erin K Schubert; Robert B Livingston
Journal:  Acad Radiol       Date:  2004-10       Impact factor: 3.173

9.  TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.

Authors:  Roisin M Connolly; Jeffrey P Leal; Lilja Solnes; Chiung-Yu Huang; Ashley Carpenter; Katy Gaffney; Vandana Abramson; Lisa A Carey; Minetta C Liu; Mothaffar Rimawi; Jennifer Specht; Anna Maria Storniolo; Vicente Valero; Christos Vaklavas; Ian E Krop; Eric P Winer; Melissa Camp; Robert S Miller; Antonio C Wolff; Ashley Cimino-Mathews; Ben H Park; Richard L Wahl; Vered Stearns
Journal:  J Clin Oncol       Date:  2019-02-05       Impact factor: 44.544

Review 10.  Radionuclide methods and instrumentation for breast cancer detection and diagnosis.

Authors:  Suleman Surti
Journal:  Semin Nucl Med       Date:  2013-07       Impact factor: 4.446
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.